These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 17341731)
1. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731 [TBL] [Abstract][Full Text] [Related]
2. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT. de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604 [TBL] [Abstract][Full Text] [Related]
3. Osteochondromas: review of the clinical, radiological and pathological features. Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760 [TBL] [Abstract][Full Text] [Related]
4. A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. Signori E; Massi E; Matera MG; Poscente M; Gravina C; Falcone G; Rosa MA; Rinaldi M; Wuyts W; Seripa D; Dallapiccola B; Fazio VM Genes Chromosomes Cancer; 2007 May; 46(5):470-7. PubMed ID: 17301954 [TBL] [Abstract][Full Text] [Related]
5. The neoplastic pathogenesis of solitary and multiple osteochondromas. Porter DE; Simpson AH J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153 [TBL] [Abstract][Full Text] [Related]
6. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Szuhai K; Jennes I; de Jong D; Bovée JV; Wiweger M; Wuyts W; Hogendoorn PC Hum Mutat; 2011 Feb; 32(2):E2036-49. PubMed ID: 21280143 [TBL] [Abstract][Full Text] [Related]
7. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760 [TBL] [Abstract][Full Text] [Related]
8. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation. Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910 [TBL] [Abstract][Full Text] [Related]
9. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Bovée JV; Cleton-Jansen AM; Wuyts W; Caethoven G; Taminiau AH; Bakker E; Van Hul W; Cornelisse CJ; Hogendoorn PC Am J Hum Genet; 1999 Sep; 65(3):689-98. PubMed ID: 10441575 [TBL] [Abstract][Full Text] [Related]
10. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations. Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175 [TBL] [Abstract][Full Text] [Related]
11. [From gene to disease; hereditary multiple exostoses]. Wuyts W; Bovée JV; Hogendoorn PC Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438 [TBL] [Abstract][Full Text] [Related]
13. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766 [TBL] [Abstract][Full Text] [Related]
14. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Bridge JA; Nelson M; Orndal C; Bhatia P; Neff JR Cancer; 1998 May; 82(9):1657-63. PubMed ID: 9576285 [TBL] [Abstract][Full Text] [Related]
15. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis. Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899 [TBL] [Abstract][Full Text] [Related]
16. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma. Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962 [TBL] [Abstract][Full Text] [Related]
17. Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma. Feely MG; Boehm AK; Bridge RS; Krallman PA; Neff JR; Nelson M; Bridge JA Cancer Genet Cytogenet; 2002 Sep; 137(2):102-7. PubMed ID: 12393280 [TBL] [Abstract][Full Text] [Related]
18. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. Jennes I; Entius MM; Van Hul E; Parra A; Sangiorgi L; Wuyts W J Mol Diagn; 2008 Jan; 10(1):85-92. PubMed ID: 18165274 [TBL] [Abstract][Full Text] [Related]
19. RNA-Seq detects a SAMD12-EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas. Oliver GR; Blackburn PR; Ellingson MS; Conboy E; Pinto E Vairo F; Webley M; Thorland E; Ferber M; Van Hul E; van der Werf IM; Wuyts W; Babovic-Vuksanovic D; Klee EW Mol Genet Genomic Med; 2019 Mar; 7(3):e00560. PubMed ID: 30632316 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a novel member of the EXT gene family, EXTL2. Wuyts W; Van Hul W; Hendrickx J; Speleman F; Wauters J; De Boulle K; Van Roy N; Van Agtmael T; Bossuyt P; Willems PJ Eur J Hum Genet; 1997; 5(6):382-9. PubMed ID: 9450183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]